Along with its devastating well being toll, COVID-19 also can result in vital monetary prices for folks needing therapy and for private and non-private payers. This evaluation examines the price of COVID-19 therapy for inpatient care amongst folks with well being protection via giant employers.
It finds that in 2020, COVID-19 hospitalizations value a median of $41,611, together with a median out-of-pocket fee of $1,280 for folks with giant employer protection. In 2020, many non-public insurers and employers briefly waived out-of-pocket prices for COVID-19 therapy (that is typically not the case). For COVID-19 hospitalizations with some cost-sharing expense, a median of $1,880 was spent out-of-pocket by people with giant employer protection, although COVID-19 hospitalization prices differ broadly for sufferers with non-public insurance coverage.
This evaluation focuses on folks with giant employer protection and doesn’t replicate prices for sufferers with Medicaid or Medicare. Right now, 2020 is the latest yr of accessible information, and hospitalization and different therapy prices might have modified with the introduction of newer remedies.
The evaluation is on the market via the KFF-Peterson Well being System Tracker, a web-based info hub that displays and assesses the efficiency of the U.S. well being system.